Pulmonary Mucormycosis due to Lichtheimia ramosa in a Patient with HIV Infection

Mycopathologia

Volumn 178, Issue 1-2, 2014, Pages 111-115

  Kutlu, Murat ^a   Ergin, Çaǧri ^a   Bir, Ferda ^a   Hilmioǧlu Polat, Süleyha ^b   Gümral, Ramazan ^c   Necan, Ceyda ^a   Koçyiǧit, Ali ^a   Sayin Kutlu, Selda ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

HIV infection; Lichtheimia ramosa; Pulmonary mucormycosis

Indexed keywords

FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; MUCORALES;

ANTIFUNGAL AGENT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL RESISTANCE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; CYTOCHEMISTRY; DRUG EFFECTS; FATALITY; HUMAN; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; PATHOLOGY; SPUTUM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, FUNGAL; FATAL OUTCOME; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; SPUTUM;

EID: 84904401115     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-014-9761-5     Document Type: Article

References (33)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41: 634-53.
2. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17: 1859-67.
3. Ribes JA, Vanover-Sams CA, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13: 236-301.
4. Roilides E, Kontoyiannis DP, Walsh TJ. Host defenses against zygomycetes. Clin Infect Dis. 2012;54(Suppl 1): S61-6.
5. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1): S23-34.
6. Antinori S, Nebuloni M, Magni C, et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1, 630 autopsies performed between 1984 and 2002. Am J Clin Pathol. 2009;132: 221-7.
7. Bitar D, van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15: 1395-401.
8. van den Saffele JK, Boelaert JR. Zygomycosis in HIV-positive patients: a review of the literature. Mycoses. 1996;39: 77-84.
9. Petrikkos G, Drogari-Apiranthitou M. Zygomycosis in immunocompromised non-haematological patients. Mediterr J Hematol Infect Dis. 2011;3: e2011012.
10. Alastruey-Izquierdo A, Hoffmann K, de Hoog GS, et al. Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus). J Clin Microbiol. 2010;48: 2154-70.
11. Turin L, Riva F, Galbiati G, Cainelli T. Fast, simple and highly sensitive double-rounded polymerase chain reaction assay to detect medically relevant fungi in dermatological specimens. Eur J Clin Invest. 2000;30: 511-8.
12. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98 NT. Nucl Acids Symp Ser. 1999;41: 95-8.
13. Levy E, Bia MJ. Isolated renal mucormycosis: case report and review. J Am Soc Nephrol. 1995;5: 2014-9.
14. Blázquez R, Pinedo A, Cosín J, Miralles P, Lacruz C, Bouza E. Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user. Eur J Clin Microbiol Infect Dis. 1996;15: 598-9.
15. Keogh CF, Brown JA, Phillips P, Cooperberg PL. Renal mucormycosis in an AIDS patient: imaging features and pathologic correlation. AJR Am J Roentgenol. 2003;180: 1278-80.
16. Righi E, Giacomazzi CG, Bassetti M, et al. Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient. Med Mycol. 2007;45: 637-40.
17. Abril V, Ortega E, Segarra P, Pedro F, Sabater V, Herrera A. Rhinocerebral mucormycosis in a patient with AIDS: a complication of diabetic ketoacidosis following pentamidine therapy. Clin Infect Dis. 1996;23: 845-6.
18. Boumis E, Chinello P, Conte A, et al. Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature review. AIDS. 2006;20: 136-8.
19. Bongiovanni M, Ranieri R, Ferrari D, Codecà C, Tartaro T, Uziel L. Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis. J Antimicrob Chemother. 2007;60: 192-3.
20. Merchant S, Reichman R, Koval CE. Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor. AIDS. 2007;21: 1666-9.
21. Fujii T, Takata N, Katsutani S, Kimura A. Disseminated mucormycosis in an acquired immunodeficiency syndrome (AIDS) patient. Intern Med. 2003;42: 129-30.
22. Chavanet P, Lefranc T, Bonnin A, Waldner A, Portier H. Unusual cause of pharyngeal ulcerations in AIDS. Lancet. 1990;336: 383-4.
23. Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10: 441-9.
24. Parra-Ruiz J, Peña-Monje A, Tomas-Jimenez C, Antelo-Lorenzo R, Escobar-Lara T, Hernández-Quero J. Septic arthritis due to Absidia corymbifera in a patient with HIV-1 infection. Infection. 2008;36: 279-81.
25. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982;31: 1109-14.
26. Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008;21: 620-5.
27. Smith AG, Bustamante CI, Gilmor GD. Zygomycosis (absidiomycosis) in an AIDS patient. Absidiomycosis in AIDS. Mycopathologia. 1989;105: 7-10.
28. Lee BL, Holland GN, Glasgow BJ. Chiasmal infarction and sudden blindness caused by mucormycosis in AIDS and diabetes mellitus. Am J Ophthalmol. 1996;122: 895-6.
29. Pedro-de-Lelis FJ, Sabater-Marco V, Herrera-Ballester A. Necrotizing maxillary sinus mucormycosis related to candidiasis and microsporidiosis in an AIDS patient. AIDS. 1995;9: 1386-8.
30. Virally ML, Riveline JP, Virally J, et al. Pulmonary mucormycosis in a diabetic patient with HIV. Diabetes Care. 2002;25: 2105.
31. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48: 1743-51.
32. Alastruey-Izquierdo A, Cuesta I, Walther G, Cuenca-Estrella M, Rodriguez-Tudela JL. Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrob Agents Chemother. 2010;54: 3058-60.
33. Vitale RG, de Hoog GS, Schwarz P, et al. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol. 2012;50: 66-75.